Guardant Health (GH) Tops Q2 EPS by 26c ; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St futures kick off September under pressure as yields, oil prices rise
- Oil up around 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- The Warsh pivot markets didn't expect
- Oil settles up by more than 2.5% as US and Iran resume military attacks
Guardant Health (GH) PT Raised to $40 at Jefferies
August 8, 2024 6:47 AM EDTJefferies analyst Tycho Peterson raised the price target on Guardant Health (NASDAQ: GH) to $40.00 (from $32.00) while maintaining a Buy rating.
The analyst comments "After months of scrutiny on Shield, GH's core therapy selection business stole back some of the spotlight, as G360... More
